journal article·2024-04

“Kupffer Cell Teleportation” Strategy for Liver Fibrosis Alleviation Based on Hybrid Polymer‐ Bimetallic Sequential Delivery System

Zitong Qiu, Valentin A. Milichko, Yue Zhou, Huaqing Jing, Qiang Lu, Haobo Wang, Bei Kang, Xinxing Wang, Nan Li

Advanced Functional Materials· Volume 34· Issue 14
Publisher page

Abstract

Abstract Although direct hepatic stellate cell (HSC) inhibition is considered a promising strategy for alleviating liver fibrosis, traditional therapies struggle with off‐target effects due to limited penetration of liver sinusoidal endothelial cell barriers. This study reports on the development of a “Kupffer cell (KC) teleportation” strategy to treat liver fibrosis by fabricating a hybrid polymer‐bimetallic sequential delivery system, CF@BPPM (baicalin prodrug polymer [BP]/mannose derivative polymer [PM] encapsulated copper [Cu]‐iron [Fe] ultrasmall nanoparticles [CFs]). The nanosystems exhibit KCs targeting and acidic response sequential release properties by a hybrid polymer, which first releases CFs in lysosome after being internalized by KCs through a PM targeting effect. The exposed CFs efficiently scavenge reactive oxygen species in KCs and subsequently degrade Cu2+/ Fe2+ to upregulate the heme oxygenase expression for suppressing interleukin 1β, interleukin 6, tumor necrosis factor‐alpha, and platelet‐derived growth factors. Second, baicalin, released from BP in lysosome, further inhibits transforming growth factor beta secretion. These results suggest that CF@BPPM inhibits the inclusive cytokine secretion of KCs, which play a vital conductive role in liver fibrosis progression. Subsequently, CF@BPPM achieves protection against HSCs activation, migration, and collagen production, enriching anti‐liver fibrosis therapeutic methods by exploiting messaging between KCs and HSCs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Organ Transplantation Techniques and Outcomes · Liver Disease Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tianjin Key Laboratory of Drug Delivery & High‐Efficiency School of Pharmaceutical Science and Technology Tianjin University Tianjin 300072 P. R. China

School of Physics and Engineering ITMO University St. Petersburg 197101 Russia

Tianjin Institute of Environmental and Operational Medicine Tianjin 300050 P. R. China

Funding

Natural Science Foundation of Tianjin Municipality · Key Technologies Research and Development Program · Young Elite Scientists Sponsorship Program by Tianjin

References (43)

Show source-provided references
1. 10.1111/liv.1368210.1111/liv.13682 ↗
2. 10.1016/j.jhep.2019.03.00410.1016/j.jhep.2019.03.004 ↗
3. 10.3389/fcell.2020.0070910.3389/fcell.2020.00709 ↗
4. 10.1002/hep.2733210.1002/hep.27332 ↗
5. 10.1038/s41575-020-00372-710.1038/s41575-020-00372-7 ↗
6. 10.1002/hep.2295010.1002/hep.22950 ↗
7. 10.4049/jimmunol.178.8.528810.4049/jimmunol.178.8.5288 ↗
8. 10.1073/pnas.140006211110.1073/pnas.1400062111 ↗
9. 10.1038/s41575-018-0020-y10.1038/s41575-018-0020-y ↗
10. 10.1053/j.gastro.2011.12.01710.1053/j.gastro.2011.12.017 ↗
11. 10.1002/hep.2235110.1002/hep.22351 ↗
12. 10.1016/j.addr.2017.05.00710.1016/j.addr.2017.05.007 ↗
13. 10.1016/j.jconrel.2021.11.03310.1016/j.jconrel.2021.11.033 ↗
14. 10.1021/acsnano.1c0098810.1021/acsnano.1c00988 ↗
15. 10.1016/j.biomaterials.2019.11961610.1016/j.biomaterials.2019.119616 ↗
16. 10.1002/j.2040-4603.2013.tb00510.x10.1002/j.2040-4603.2013.tb00510.x ↗
17. 10.1038/nmat471810.1038/nmat4718 ↗
18. 10.1111/j.1478-3231.2006.01342.x10.1111/j.1478-3231.2006.01342.x ↗
19. 10.1172/JCI3054210.1172/JCI30542 ↗
20. 10.1097/01.alc.0000191128.54871.4010.1097/01.alc.0000191128.54871.40 ↗
21. 10.1002/jlb.63.5.53410.1002/jlb.63.5.534 ↗
22. 10.1038/nri173310.1038/nri1733 ↗
23. 10.1073/pnas.111996410910.1073/pnas.1119964109 ↗
24. 10.1111/jgh.1316310.1111/jgh.13163 ↗
25. 10.1038/nri285810.1038/nri2858 ↗
26. 10.1021/acs.molpharmaceut.1c0090510.1021/acs.molpharmaceut.1c00905 ↗
27. 10.2741/ponnappa10.2741/ponnappa ↗
28. 10.1053/j.gastro.2010.03.05210.1053/j.gastro.2010.03.052 ↗
29. 10.1038/labinvest.2017.6510.1038/labinvest.2017.65 ↗
30. 10.1136/gut.2005.08869010.1136/gut.2005.088690 ↗
31. 10.1002/hep.2459910.1002/hep.24599 ↗
32. 10.4049/jimmunol.179.6.403510.4049/jimmunol.179.6.4035 ↗
33. 10.1016/j.ejpb.2021.12.00110.1016/j.ejpb.2021.12.001 ↗
34. 10.1021/acs.molpharmaceut.6b0077310.1021/acs.molpharmaceut.6b00773 ↗
35. 10.1016/j.phrs.2021.10544410.1016/j.phrs.2021.105444 ↗
36. 10.1021/jacs.8b1185610.1021/jacs.8b11856 ↗
37. 10.1021/acs.jpcc.9b0780210.1021/acs.jpcc.9b07802 ↗
38. 10.1016/j.bioactmat.2022.05.02110.1016/j.bioactmat.2022.05.021 ↗
39. 10.1042/bj154012510.1042/bj1540125 ↗
40. 10.1016/j.abb.2018.01.00610.1016/j.abb.2018.01.006 ↗
41. 10.1038/s41467-020-16544-710.1038/s41467-020-16544-7 ↗
42. 10.3109/13880209.2010.49317910.3109/13880209.2010.493179 ↗
43. 10.1038/nri.2017.1110.1038/nri.2017.11 ↗